|
|
|
|
Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4
|
|
|
|
|
|
|
|
نویسنده
|
delcuratolo m. ,fertey j. ,schneider m. ,schuetz j. ,leiprecht n. ,hudjetz b. ,brodbeck s. ,corall s. ,dreer m. ,schwab r.m. ,grimm m. ,wu s.-y. ,stubenrauch f. ,chiang c.-m. ,iftner t.
|
|
منبع
|
plos pathogens - 2016 - دوره : 12 - شماره : 1
|
|
چکیده
|
We investigated the mechanism of how the papillomavirus e2 transcription factor can activate promoters through activator protein (ap)1 binding sites. using an unbiased approach with an inducible cell line expressing the viral transcription factor e2 and transcriptome analysis,we found that e2 induces the expression of the two ap1 components c-fos and fosb in a brd4-dependent manner. in vitro rna interference confirmed that c-fos is one of the ap1 members driving the expression of viral oncogenes e6/e7. mutation analysis and in vivo rna interference identified an essential role for c-fos/ap1 and also for the bromodomain protein brd4 for papillomavirus-induced tumorigenesis. lastly,chromatin immunoprecipitation analysis demonstrated that e2 binds together with brd4 to a canonical e2 binding site (e2bs) in the promoter of c-fos,thus activating c-fos expression. thus,we identified a novel way how e2 activates the viral oncogene promoter and show that e2 may act as a viral oncogene by direct activation of c-fos involved in skin tumorigenesis. © 2016 delcuratolo et al.
|
|
|
|
|
آدرس
|
division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, department of oral and maxillofacial surgery,university hospital tübingen,tübingen, Germany, university of texas southwestern medical center,simmons comprehensive cancer center,department of biochemistry,department of pharmacology,dallas,tx, United States, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany, university of texas southwestern medical center,simmons comprehensive cancer center,department of biochemistry,department of pharmacology,dallas,tx, United States, division of experimental virology,institute of medical virology,university hospital tübingen,tübingen, Germany
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|